Latest News Archive
Please select Category, Year, and then Month to display items
01 October 2019
|
Story Prof Francis Petersen
|
Photo Pixabay
During October, the national focus is on mental health. Mental Health Awareness Month also coincides with a time when our students prepare for the end of the year exams, making it a particularly valuable time for us to think about how we can continuously assist them during their time at university. The value of peer support and genuine care can never be overstressed; that is why I want to encourage our students to reach out to their support networks such as our Department of Student Counselling and Development, as we move towards the end of the year.
Mental health is an equally important matter for our staff. During this month, I want to encourage our staff to also take cognisance of their own well-being. There is a lot of wisdom in the old adage: Healthy body, healthy mind. Many of the initiatives of our Division of Organisational Development and Employee Wellness are focused on the value of physical activity and the negative impact that inactivity can have on one’s productivity and mental health. They also present regular lunch-hour sessions for our staff, where experts share information and practical tips for mental wellness. I want to encourage our staff to attend these sessions and to make use of the services the university has to offer in this regard. It is important to note that suffering from mental and anxiety disorders is not weaknesses and it is not always indicative of a deeper psychological issue; it is an illness and hence can be treated.
On 20 September 2019, a 21-member team was sent off on their run of 1 075 km to Stellenbosch to raise awareness for mental health. The run was organised by the Division of Organisational Development and Employee Wellness and the Faculty of Health Sciences. The team ran in relay format throughout the night and handed the baton of hope to Stellenbosch University on 25 September 2019. I admire and thank them not only for their commitment and stamina, but also for addressing this crucial matter in the public domain and for raising awareness in the many towns and communities along the way.
This is an excerpt from a message by Prof Francis Petersen.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004